A randomised, placebo-controlled trial of the effects of IV serelaxin on myocardial blood flow and vascular function in patients with stable coronary artery disease (CAD)
European Heart Journal（2017）
Key words
iv serelaxin,stable coronary artery disease,myocardial blood flow,coronary artery disease,vascular function,placebo-controlled
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined